| Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ... Nature medicine 20 (11), 1301-1309, 2014 | 1124 | 2014 |
| Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ... Nature 507 (7490), 109-113, 2014 | 683 | 2014 |
| Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ... Nature 490 (7420), 412-416, 2012 | 638 | 2012 |
| 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma H Poeck, R Besch, C Maihoefer, M Renn, D Tormo, SS Morskaya, ... Nature medicine 14 (11), 1256-1263, 2008 | 501 | 2008 |
| A comparison of two types of dendritic cell as adjuvants for the induction of melanoma‐specific T‐cell responses in humans following intranodal injection H Jonuleit, A Giesecke‐Tuettenberg, T Tüting, B Thurner‐Schuler, ... International journal of cancer 93 (2), 243-251, 2001 | 484 | 2001 |
| Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing N Gehrke, C Mertens, T Zillinger, J Wenzel, T Bald, S Zahn, T Tüting, ... Immunity 39 (3), 482-495, 2013 | 468 | 2013 |
| Attenuation of allergic contact dermatitis through the endocannabinoid system M Karsak, E Gaffal, R Date, L Wang-Eckhardt, J Rehnelt, S Petrosino, ... science 316 (5830), 1494-1497, 2007 | 408 | 2007 |
| The experimental power of FR900359 to study Gq-regulated biological processes R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ... Nature communications 6 (1), 10156, 2015 | 382 | 2015 |
| Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease P Koch, P Breuer, M Peitz, J Jungverdorben, J Kesavan, D Poppe, J Doerr, ... Nature 480 (7378), 543-546, 2011 | 376 | 2011 |
| Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin SL Park, A Buzzai, J Rautela, JL Hor, K Hochheiser, M Effern, N McBain, ... Nature 565 (7739), 366-371, 2019 | 369 | 2019 |
| Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? M Hölzel, A Bovier, T Tüting Nature Reviews Cancer 13 (5), 365-376, 2013 | 321 | 2013 |
| Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive … MJ Reinhardt, AY Joe, U Jaeger, A Huber, A Matthies, J Bucerius, ... Journal of clinical oncology 24 (7), 1178-1187, 2006 | 320 | 2006 |
| Immune cell–poor melanomas benefit from PD-1 blockade after targeted type I IFN activation T Bald, J Landsberg, D Lopez-Ramos, M Renn, N Glodde, P Jansen, ... Cancer discovery 4 (6), 674-687, 2014 | 298 | 2014 |
| Depletion of CD25+ CD4+ T Cells and Treatment with Tyrosinase-related Protein 2-transduced Dendritic Cells Enhance the Interferon α-induced, CD8+ T-Cell … J Steitz, J Brück, J Lenz, J Knop, T Tüting Cancer research 61 (24), 8643-8646, 2001 | 287 | 2001 |
| Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by … T Tuting, CC Wilson, DM Martin, YL Kasamon, J Rowles, DI Ma, ... The Journal of Immunology 160 (3), 1139-1147, 1998 | 273 | 1998 |
| Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus J Wenzel, E Wörenkämper, S Freutel, S Henze, O Haller, T Bieber, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 270 | 2005 |
| Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ... Immunity 47 (4), 789-802. e9, 2017 | 266 | 2017 |
| Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells D Tormo, A Chęcińska, D Alonso-Curbelo, E Pérez-Guijarro, E Cañón, ... Cancer cell 16 (2), 103-114, 2009 | 242 | 2009 |
| Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma P Falletta, L Sanchez-del-Campo, J Chauhan, M Effern, A Kenyon, ... Genes & development 31 (1), 18-33, 2017 | 240 | 2017 |
| Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope A Gambotto, G Dworacki, V Cicinnati, T Kenniston, J Steitz, T Tüting, ... Gene therapy 7 (23), 2036-2040, 2000 | 233 | 2000 |
